Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1983 Nov;72(5):1729–1736. doi: 10.1172/JCI111132

Studies of liver insulin receptors in non-obese and obese human subjects.

P Arner, K Einarsson, L Backman, K Nilsell, K M Lerea, J N Livingston
PMCID: PMC370461  PMID: 6355185

Abstract

The insulin-binding isotherms and the structural composition of human liver insulin receptors were examined by using plasma membranes that were prepared from liver biopsies of nine non-obese and 10 obese subjects undergoing elective surgery. The insulin-binding characteristics of liver membranes from non-obese subjects were quite similar to those previously described in rat liver membranes. However, when the membranes from obese subjects were compared with the non-obese group, insulin-binding activity was reduced by 50% (P less than 0.01). The reduction in obesity resulted primarily from a decrease in total receptor number, although a small decrease in receptor affinity was also observed. Insulin binding was not correlated with sex or with the fasting plasma insulin level. The insulin-binding sites of liver membranes were affinity-labeled with 125I-insulin and the cross-linking reagent, disuccinimidyl suberate. The liver membranes from both the non-obese and the obese group had heterogenous (nonreduced) insulin-binding species of 300,000, 260,000, and 150,000 mol wt, which were again comparable to the findings reported in rat liver. Sulfhydryl reduction demonstrated a major sub-unit of 125,000 and a minor component of 40,000-45,000 in both groups. These results indicate a close similarity between the hepatic insulin receptor of man and the more intensely studied rat hepatic receptor. Obesity in human subjects is associated with a loss of hepatic insulin receptors. This alteration may contribute to the insulin resistance reported in this organ as well as to obesity-mediated glucose tolerance.

Full text

PDF
1729

Images in this article

1734Image
on p.1734
1734Image
on p.1734

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Amatruda J. M., Livingston J. N., Lockwood D. H. Insulin receptor: role in the resistance of human obesity to insulin. Science. 1975 Apr 18;188(4185):264–266. doi: 10.1126/science.164059. [DOI] [PubMed] [Google Scholar]
  2. Archer J. A., Gorden P., Roth J. Defect in insulin binding to receptors in obese man. Amelioration with calorie restriction. J Clin Invest. 1975 Jan;55(1):166–174. doi: 10.1172/JCI107907. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Aronson N. N., Jr, Touster O. Isolation of rat liver plasma membrane fragments in isotonic sucrose. Methods Enzymol. 1974;31:90–102. doi: 10.1016/0076-6879(74)31009-9. [DOI] [PubMed] [Google Scholar]
  4. Bar R. S., Gorden P., Roth J., Kahn C. R., De Meyts P. Fluctuations in the affinity and concentration of insulin receptors on circulating monocytes of obese patients: effects of starvation, refeeding, and dieting. J Clin Invest. 1976 Nov;58(5):1123–1135. doi: 10.1172/JCI108565. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  6. Coburn H. J., Carroll J. J. Improved manual and automated colorimetric determination of serum glucose, with use of hexokinase and glucose-6-phosphate dehydrogenase. Clin Chem. 1973 Jan;19(1):127–130. [PubMed] [Google Scholar]
  7. D'Ercole A. J., Underwood L. E., Groelke J., Plet A. Leprechaunism: studies of the relationship among hyperinsulinism, insulin resistance, and growth retardation. J Clin Endocrinol Metab. 1979 Mar;48(3):495–502. doi: 10.1210/jcem-48-3-495. [DOI] [PubMed] [Google Scholar]
  8. De Pirro R., Fusco A., Lauro R., Testa I., Ferretti G., De Martinis C. Insulin receptors on monocytes and erythrocytes from obese patients. J Clin Endocrinol Metab. 1980 Dec;51(6):1437–1439. doi: 10.1210/jcem-51-6-1437. [DOI] [PubMed] [Google Scholar]
  9. Felig P., Wahren J., Hendler R., Brundin T. Splanchnic glucose and amino acid metabolism in obesity. J Clin Invest. 1974 Feb;53(2):582–590. doi: 10.1172/JCI107593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Felig P., Wahren J., Hendler R. Influence of oral glucose ingestion on splanchnic glucose and gluconeogenic substrate metabolism in man. Diabetes. 1975 May;24(5):468–475. doi: 10.2337/diab.24.5.468. [DOI] [PubMed] [Google Scholar]
  11. Gambhir K. K., Archer J. A., Bradley C. J. Characteristics of human erythrocyte insulin receptors. Diabetes. 1978 Jul;27(7):701–708. doi: 10.2337/diab.27.7.701. [DOI] [PubMed] [Google Scholar]
  12. Gavin J. R., 3rd, Gorden P., Roth J., Archer J. A., Buell D. N. Characteristics of the human lymphocyte insulin receptor. J Biol Chem. 1973 Mar 25;248(6):2202–2207. [PubMed] [Google Scholar]
  13. Gavin J. R., 3rd, Roth J., Neville D. M., Jr, de Meyts P., Buell D. N. Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture. Proc Natl Acad Sci U S A. 1974 Jan;71(1):84–88. doi: 10.1073/pnas.71.1.84. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Gould R. J., Ginsberg B. H., Spector A. A. Lipid effects on the binding properties of a reconstituted insulin receptor. J Biol Chem. 1982 Jan 10;257(1):477–484. [PubMed] [Google Scholar]
  15. Harrison L. C., Billington T., East I. J., Nichols R. J., Clark S. The effect of solubilization on the properties of the insulin receptor of human placental membranes. Endocrinology. 1978 May;102(5):1485–1495. doi: 10.1210/endo-102-5-1485. [DOI] [PubMed] [Google Scholar]
  16. Harrison L. C., Martin F. I., Melick R. A. Correlation between insulin receptor binding in isolated fat cells and insulin sensitivity in obese human subjects. J Clin Invest. 1976 Dec;58(6):1435–1441. doi: 10.1172/JCI108599. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kahn C. R., Neville D. M., Jr, Roth J. Insulin-receptor interaction in the obese-hyperglycemic mouse. A model of insulin resistance. J Biol Chem. 1973 Jan 10;248(1):244–250. [PubMed] [Google Scholar]
  18. Klotz I. M. Numbers of receptor sites from Scatchard graphs: facts and fantasies. Science. 1982 Sep 24;217(4566):1247–1249. doi: 10.1126/science.6287580. [DOI] [PubMed] [Google Scholar]
  19. Kolterman O. G., Insel J., Saekow M., Olefsky J. M. Mechanisms of insulin resistance in human obesity: evidence for receptor and postreceptor defects. J Clin Invest. 1980 Jun;65(6):1272–1284. doi: 10.1172/JCI109790. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Kolterman O. G., Reaven G. M., Olefsky J. M. Relationship between in vivo insulin resistance and decreased insulin receptors in obese man. J Clin Endocrinol Metab. 1979 Mar;48(3):487–494. doi: 10.1210/jcem-48-3-487. [DOI] [PubMed] [Google Scholar]
  21. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970 Aug 15;227(5259):680–685. doi: 10.1038/227680a0. [DOI] [PubMed] [Google Scholar]
  22. Lesko L., Donlon M., Marinetti G. V., Hare J. D. A rapid method for the isolation of rat liver plasma membranes using an aqueous two-phase polymer system. Biochim Biophys Acta. 1973 Jun 22;311(2):173–179. doi: 10.1016/0005-2736(73)90264-2. [DOI] [PubMed] [Google Scholar]
  23. Lockwood D. H., Hamilton C. L., Livingston J. N. The influence of obesity and diabetes in the monkey on insulin and glucagon binding to liver membranes. Endocrinology. 1979 Jan;104(1):76–81. doi: 10.1210/endo-104-1-76. [DOI] [PubMed] [Google Scholar]
  24. Massague J., Pilch P. F., Czech M. P. A unique proteolytic cleavage site on the beta subunit of the insulin receptor. J Biol Chem. 1981 Apr 10;256(7):3182–3190. [PubMed] [Google Scholar]
  25. Massaqué J., Czech M. P. Multiple redox forms of the insulin receptor in native liver membranes. Diabetes. 1980 Nov;29(11):945–947. doi: 10.2337/diab.29.11.945. [DOI] [PubMed] [Google Scholar]
  26. Misbin R. I., O'Leary J. P., Pulkkinen A. Insulin receptor binding in obesity: a reassessment. Science. 1979 Sep 7;205(4410):1003–1004. doi: 10.1126/science.472718. [DOI] [PubMed] [Google Scholar]
  27. Neufeld N. D., Scott M., Kaplan S. A. Ontogeny of the mammalian insulin receptor. Studies of human and rat fetal liver plasma membranes. Dev Biol. 1980 Jul;78(1):151–160. doi: 10.1016/0012-1606(80)90325-5. [DOI] [PubMed] [Google Scholar]
  28. Olefsky J. M. Decreased insulin binding to adipocytes and circulating monocytes from obese subjects. J Clin Invest. 1976 May;57(5):1165–1172. doi: 10.1172/JCI108384. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Olefsky J. M. LIlly lecture 1980. Insulin resistance and insulin action. An in vitro and in vivo perspective. Diabetes. 1981 Feb;30(2):148–162. doi: 10.2337/diab.30.2.148. [DOI] [PubMed] [Google Scholar]
  30. Pilch P. F., Czech M. P. Interaction of cross-linking agents with the insulin effector system of isolated fat cells. Covalent linkage of 125I-insulin to a plasma membrane receptor protein of 140,000 daltons. J Biol Chem. 1979 May 10;254(9):3375–3381. [PubMed] [Google Scholar]
  31. Pollet R. J., Kempner E. S., Standaert M. L., Haase B. A. Structure of the insulin receptor of the cultured human lymphoblastoid cell IM-9. Evidence suggesting that two subunits are required for insulin binding. J Biol Chem. 1982 Jan 25;257(2):894–898. [PubMed] [Google Scholar]
  32. Pottick L. A., Moxley R. T., 3rd, Livingston J. N. Tissue differences in insulin receptors: acute changes in insulin binding characteristics induced by wheat germ agglutinin. Diabetes. 1981 Mar;30(3):196–202. doi: 10.2337/diab.30.3.196. [DOI] [PubMed] [Google Scholar]
  33. Rechler M. M., Podskalny J. M. Insulin receptors in cultured human fibroblasts. Diabetes. 1976 Apr;25(4):250–255. doi: 10.2337/diab.25.4.250. [DOI] [PubMed] [Google Scholar]
  34. Rodbell M., Krans H. M., Pohl S. L., Birnbaumer L. The glucagon-sensitive adenyl cyclase system in plasma membranes of rat liver. 3. Binding of glucagon: method of assay and specificity. J Biol Chem. 1971 Mar 25;246(6):1861–1871. [PubMed] [Google Scholar]
  35. Roth J. Insulin binding to its receptor: is the receptor more important than the hormone? Diabetes Care. 1981 Jan-Feb;4(1):27–32. doi: 10.2337/diacare.4.1.27. [DOI] [PubMed] [Google Scholar]
  36. Savage P. J., Hamman R. F., Bennett P. H. Prediabetes in the Pima Indians. Adv Exp Med Biol. 1979;119:13–19. doi: 10.1007/978-1-4615-9110-8_3. [DOI] [PubMed] [Google Scholar]
  37. Weber K., Pringle J. R., Osborn M. Measurement of molecular weights by electrophoresis on SDS-acrylamide gel. Methods Enzymol. 1972;26:3–27. doi: 10.1016/s0076-6879(72)26003-7. [DOI] [PubMed] [Google Scholar]
  38. Yip C. C., Yeung C. W., Moule M. L. Photoaffinity labeling of insulin receptor proteins of liver plasma membrane preparations. Biochemistry. 1980 Jan 8;19(1):70–76. doi: 10.1021/bi00542a011. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES